Literature DB >> 15942466

The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis.

Nicola De Luca1, Raffaele Izzo, Guido Iaccarino, Pier Luigi Malini, Carmine Morisco, Francesco Rozza, Gianni Luigi Iovino, Maria Assunta Elena Rao, Clara Bodenizza, Francesca Lanni, Luigi Guerrera, Oreste Arcucci, Bruno Trimarco.   

Abstract

BACKGROUND: Inadequate blood pressure (BP) control could be due to incorrect management of hypertensives caused by the lack of interaction between general practitioners (GP) and hypertension specialists.
OBJECTIVES: To test the effectiveness on BP and total cardiovascular risk (TCVR) control of an internet-based digital network connecting specialists and GPs.
METHODS: We created a network among the Hypertension Clinic, Federico II University (Naples, Italy), 23 hospital-based hypertension clinics and 60 GPs from the area (CampaniaSalute Network, CS). Randomized GPs enrolled in CS could update online records of patients (n = 1979). As a control, we included 2045 patients referred to the specialist clinics by GPs from outside the network. All patients completed a 2-year follow-up.
RESULTS: CS provided a larger reduction in BP [systolic/diastolic BP (SBP/DBP): 7.3 +/- 0.4/5.4 +/- 0.3 versus 4.1 +/- 0.4/3.1 +/- 0.26 mmHg, CS versus control; P < 0.001 for both] and percentage of patients with BP < 140/90 mmHg (CS versus control: baseline, 33 versus 34%, NS; end of follow-up, 51 versus 47%, chi = 13.371; P < 0.001). A European Society of Hypertension-European Society of Cardiology (ESH/ESC) TCVR score was calculated [from 1 (average) to 5 (very high TCVR)]. The CS group showed a reduction in the mean TCVR score (CS: from 3.5 +/- 0.02 to 3.2 +/- 0, P < 0.01, ANOVA; control group: 3.5 +/- 0.03 to 3.4 +/- 0.03, NS) and, accordingly, fatal and non-fatal major cardiovascular events (MACE) were less frequent (2.9 versus 4.3%; chi = 5.047, P < 0.02). CS predicts fewer MACE in multiple binary regression analysis (beta:-7.27, P < 0.008) reducing the risk for MACE compared to control [odds ratio (OR): 0.838; 95% confidence interval (CI): 0.73-0.96].
CONCLUSION: Our results support the idea that telemedicine can achieve better control of BP and TCVR.

Entities:  

Mesh:

Year:  2005        PMID: 15942466     DOI: 10.1097/01.hjh.0000173526.65555.55

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  24 in total

1.  Should thiazide diuretics be given as first line antihypertensive therapy or in addition to other medications?

Authors:  Valentina Trimarco; Raffaele Izzo; Teresa Migliore; Francesco Rozza; Marina Marino; Maria Virginia Manzi; Marina De Marco; Giovanni de Simone; Nicola De Luca
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-06-24

2.  Antihypertensive response to combination of olmesartan and amlodipine does not depend on method and time of drug administration.

Authors:  Francesco Rozza; Valentina Trimarco; Raffaele Izzo; Mario Santoro; Maria Virginia Manzi; Marina Marino; Gianfranco Di Renzo; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-05-09

Review 3.  Hypertension Survey in Italy: Novel Findings from the Campania Salute Network.

Authors:  Eugenio Stabile; Raffaele Izzo; Francesco Rozza; Maria Angela Losi; Nicola De Luca; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-01

4.  Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension.

Authors:  R Esposito; R Izzo; M Galderisi; M De Marco; E Stabile; G Esposito; V Trimarco; F Rozza; N De Luca; G de Simone
Journal:  J Hum Hypertens       Date:  2015-09-10       Impact factor: 3.012

5.  The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events.

Authors:  Gennaro Galasso; Gaetano Santulli; Federico Piscione; Roberta De Rosa; Valentina Trimarco; Raffaele Piccolo; Salvatore Cassese; Guido Iaccarino; Bruno Trimarco; Massimo Chiariello
Journal:  BMC Cardiovasc Disord       Date:  2010-09-16       Impact factor: 2.298

6.  TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.

Authors:  Martina Chittani; Roberta Zaninello; Chiara Lanzani; Francesca Frau; Maria F Ortu; Erika Salvi; Giovanni Fresu; Lorena Citterio; Daniele Braga; Daniela A Piras; Simona Delli Carpini; Dinesh Velayutham; Marco Simonini; Giuseppe Argiolas; Simona Pozzoli; Chiara Troffa; Valeria Glorioso; Kimmo K Kontula; Timo P Hiltunen; Kati M Donner; Stephen T Turner; Eric Boerwinkle; Arlene B Chapman; Sandosh Padmanabhan; Anna F Dominiczak; Olle Melander; Julie A Johnson; Rhonda M Cooper-Dehoff; Yan Gong; Natalia V Rivera; Gianluigi Condorelli; Bruno Trimarco; Paolo Manunta; Daniele Cusi; Nicola Glorioso; Cristina Barlassina
Journal:  J Hypertens       Date:  2015-06       Impact factor: 4.844

7.  Smoking selectively accelerates carotid atherosclerosis in hypertensive patients.

Authors:  Raffaele Izzo; Gianfranco Di Renzo; Nicola De Luca; Valentina Trimarco; Francesco Buono; Salvatore Crispo; Renata Giudice; Frazer Lowe; Mike McEwan; Francesco Rozza; Antonella Bassi; Alfredo Nunziata; Lucio Annunziato; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

8.  Lifestyle-related risk factors, smoking status and cardiovascular disease.

Authors:  Renata Giudice; Raffaele Izzo; Maria Virgina Manzi; Giampiero Pagnano; Mario Santoro; Maria Assunta Elena Rao; Gianfranco Di Renzo; Nicola De Luca; Valentina Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-06-01

9.  Lack of reduction of left ventricular mass in treated hypertension: the strong heart study.

Authors:  Giovanni de Simone; Richard B Devereux; Raffaele Izzo; Daniela Girfoglio; Elisa T Lee; Barbara V Howard; Mary J Roman
Journal:  J Am Heart Assoc       Date:  2013-06-06       Impact factor: 5.501

10.  Insufficient control of blood pressure and incident diabetes.

Authors:  Raffaele Izzo; Giovanni de Simone; Marcello Chinali; Guido Iaccarino; Valentina Trimarco; Francesco Rozza; Renata Giudice; Bruno Trimarco; Nicola De Luca
Journal:  Diabetes Care       Date:  2009-02-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.